Astera Labs, Inc. $ALAB Shares Sold by TD Private Client Wealth LLC

TD Private Client Wealth LLC cut its holdings in shares of Astera Labs, Inc. (NASDAQ:ALAB) by 52.7% in the 2nd quarter, according to its most recent disclosure with the Securities and Exchange Commission (SEC). The institutional investor owned 1,162 shares of the company’s stock after selling 1,293 shares during the period. TD Private Client Wealth LLC’s holdings in Astera Labs were worth $105,000 as of its most recent SEC filing.

Other large investors also recently modified their holdings of the company. Oliver Lagore Vanvalin Investment Group acquired a new stake in shares of Astera Labs during the second quarter valued at about $29,000. Sound Income Strategies LLC grew its stake in Astera Labs by 34.7% in the first quarter. Sound Income Strategies LLC now owns 792 shares of the company’s stock worth $47,000 after purchasing an additional 204 shares in the last quarter. GAMMA Investing LLC grew its stake in Astera Labs by 55.7% in the first quarter. GAMMA Investing LLC now owns 794 shares of the company’s stock worth $47,000 after purchasing an additional 284 shares in the last quarter. Harbour Investments Inc. grew its stake in Astera Labs by 351.7% in the first quarter. Harbour Investments Inc. now owns 795 shares of the company’s stock worth $47,000 after purchasing an additional 619 shares in the last quarter. Finally, Migdal Insurance & Financial Holdings Ltd. acquired a new position in Astera Labs in the first quarter worth about $48,000. 60.47% of the stock is currently owned by institutional investors and hedge funds.

Insider Buying and Selling at Astera Labs

In other Astera Labs news, CFO Michael Truett Tate sold 100,000 shares of Astera Labs stock in a transaction that occurred on Thursday, August 7th. The shares were sold at an average price of $171.38, for a total value of $17,138,000.00. Following the transaction, the chief financial officer owned 518,996 shares in the company, valued at approximately $88,945,534.48. The trade was a 16.16% decrease in their ownership of the stock. The transaction was disclosed in a filing with the SEC, which can be accessed through this hyperlink. Also, Director Manuel Alba sold 183,000 shares of Astera Labs stock in a transaction that occurred on Tuesday, September 2nd. The stock was sold at an average price of $173.27, for a total transaction of $31,708,410.00. Following the completion of the transaction, the director owned 385,863 shares in the company, valued at approximately $66,858,482.01. This trade represents a 32.17% decrease in their position. The disclosure for this sale can be found here. In the last ninety days, insiders have sold 1,576,027 shares of company stock worth $239,177,011. 12.50% of the stock is owned by corporate insiders.

Astera Labs Price Performance

Shares of NASDAQ:ALAB opened at $198.80 on Tuesday. Astera Labs, Inc. has a 12 month low of $47.13 and a 12 month high of $262.90. The stock has a market cap of $33.04 billion, a price-to-earnings ratio of 355.00, a PEG ratio of 5.02 and a beta of 1.46. The stock’s 50 day moving average price is $183.42 and its 200 day moving average price is $116.20.

Astera Labs (NASDAQ:ALAB) last announced its earnings results on Tuesday, August 5th. The company reported $0.44 EPS for the quarter, topping the consensus estimate of $0.33 by $0.11. Astera Labs had a return on equity of 9.53% and a net margin of 16.54%.The firm had revenue of $191.93 million for the quarter, compared to analysts’ expectations of $172.46 million. During the same quarter in the previous year, the company earned $0.13 earnings per share. The firm’s quarterly revenue was up 149.5% compared to the same quarter last year. Astera Labs has set its Q3 2025 guidance at 0.380-0.390 EPS. On average, sell-side analysts expect that Astera Labs, Inc. will post 0.34 EPS for the current year.

Analyst Upgrades and Downgrades

ALAB has been the subject of a number of research reports. Northland Securities downgraded Astera Labs from an “outperform” rating to a “market perform” rating and set a $120.00 price target for the company. in a research note on Tuesday, July 22nd. Citigroup lifted their price target on Astera Labs from $160.00 to $275.00 and gave the stock a “buy” rating in a research note on Wednesday, September 17th. CICC Research initiated coverage on Astera Labs in a research note on Friday, August 29th. They issued an “outperform” rating and a $190.00 price target for the company. Stifel Nicolaus set a $145.00 price target on Astera Labs and gave the stock a “buy” rating in a research note on Monday, August 4th. Finally, Jefferies Financial Group lifted their price target on Astera Labs from $95.00 to $130.00 and gave the stock a “buy” rating in a research note on Tuesday, July 22nd. One investment analyst has rated the stock with a Strong Buy rating, fifteen have assigned a Buy rating and three have given a Hold rating to the stock. Based on data from MarketBeat, Astera Labs currently has a consensus rating of “Moderate Buy” and an average price target of $152.94.

Astera Labs Profile

Astera Labs, Inc designs, manufactures, and sells semiconductor-based connectivity solutions for cloud and AI infrastructure. Its Intelligent Connectivity Platform is comprised of a portfolio of data, network, and memory connectivity products, which are built on a unifying software-defined architecture that enables customers to deploy and operate high performance cloud and AI infrastructure at scale.